| Trial ID: | L5410 |
| Source ID: | NCT00497536
|
| Associated Drug: |
Insulin Aspart (Iasp)
|
| Title: |
Pharmacokinetics of IAsp Following CSII in Patients With T1DM
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes Mellitus
|
| Interventions: |
DRUG: Insulin Aspart (IAsp)|DRUG: Insulin Aspart (IAsp).|DRUG: Insulin Aspart (IAsp)
|
| Outcome Measures: |
Primary: CV SSPIasp, 6 hours | Secondary: • Δ SSPIAsp (S.C. /I.V.) • AUC IAsp • Tmax IAsp • Cmax IAsp - Bioequivalence of Iasp under SS (GIR, S-FFA, S-glycerol), 6 hours
|
| Sponsor/Collaborators: |
Sponsor: University of Aarhus
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-07
|
| Completion Date: |
2008-07
|
| Results First Posted: |
|
| Last Update Posted: |
2009-02-05
|
| Locations: |
Medicinsk Endokrinologisk Afdeling M, Aarhus C, Region Midtjylland, 8000, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00497536
|
